These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16897587)

  • 1. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy.
    Gimenes VM; Criado PR; Martins JE; Almeida SR
    Mycopathologia; 2006 Aug; 162(2):97-101. PubMed ID: 16897587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis.
    Mazo Fávero Gimenes V; Da Glória de Souza M; Ferreira KS; Marques SG; Gonçalves AG; Vagner de Castro Lima Santos D; Pedroso e Silva Cde M; Almeida SR
    Microbes Infect; 2005 Apr; 7(4):708-13. PubMed ID: 15848277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.
    Tanuma H; Hiramatsu M; Mukai H; Abe M; Kume H; Nishiyama S; Katsuoka K
    Mycoses; 2000; 43(1-2):79-83. PubMed ID: 10838854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical improvement of chromoblastomycosis refractory to itraconazole successfully treated with high dose of terbinafine.
    Silva-Rocha WP; Cardoso FJ; Colalto W; Melo AS; Chaves GM
    J Dermatol; 2013 Sep; 40(9):775-6. PubMed ID: 23865635
    [No Abstract]   [Full Text] [Related]  

  • 8. Images in clinical medicine. Chromoblastomycosis.
    Brown M; Pasvol G
    N Engl J Med; 2005 May; 352(20):e19. PubMed ID: 15901855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chromomycosis acquired in a non-tropical area: A case report].
    Ouédraogo MS; Vignon-Pennamen MD; Battistella M; Levy A; Feuilhade de Chauvin M; Petit A
    Ann Dermatol Venereol; 2017; 144(6-7):438-442. PubMed ID: 28396061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK; Taborda PR; Sanzovo AD
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fonsecaea pedrosoi infection induces differential modulation of costimulatory molecules and cytokines in monocytes from patients with severe and mild forms of chromoblastomycosis.
    Sousa MG; de Maria Pedrozo e Silva Azevedo C; Nascimento RC; Ghosn EE; Santiago KL; Noal V; Bomfim GF; Marques SG; Gonçalves AG; Wagner de Castro Lima Santos D; Almeida SR
    J Leukoc Biol; 2008 Sep; 84(3):864-70. PubMed ID: 18562487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral vitamin D(3) and oral terbinafine for refractory chromoblastomycosis.
    Hussain I; Rashid T; Haroon TS
    Br J Dermatol; 2002 Apr; 146(4):704. PubMed ID: 11966710
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
    Chen Y; Yin S; Li M; Chen R; Wei L; Ma H; Deng S; de Hoog GS; Lai W; Lu C; Feng P
    Mycoses; 2016 Oct; 59(10):662-7. PubMed ID: 27330038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response in chromoblastomycosis during and after therapy.
    Esterre P; Jahevitra M; Andriantsimahavandy A
    Clin Diagn Lab Immunol; 2000 May; 7(3):497-500. PubMed ID: 10799467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromoblastomycosis caused by Cladophialophora carrionii in a child from India.
    Pradeepkumar NS; Joseph NM
    J Infect Dev Ctries; 2011 Jul; 5(7):556-60. PubMed ID: 21795827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chromoblastomycosis with terbinafine: a report of four cases.
    Xibao Z; Changxing L; Quan L; Yuqing H
    J Dermatolog Treat; 2005 Apr; 16(2):121-4. PubMed ID: 16019628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis.
    Azevedo Cde M; Marques SG; Resende MA; Gonçalves AG; Santos DV; da Silva RR; de Sousa Mda G; de Almeida SR
    Mycoses; 2008 Jul; 51(4):341-4. PubMed ID: 18444974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.